跳至主要内容
临床试验/CTRI/2025/01/078879
CTRI/2025/01/078879尚未招募2 期

A Randomized Controlled Trial To Evaluate The Efficacy Of Lakshadigana kwatha karnaprakshalana and Rasanjana Madhu karnapoorna in comparison to Fluconazole 0.3 percent Ear drops In The Treatment Of kaphajkarnashoola - Otomycosis

Dr Abhilasha1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2026年2月2日最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
100
试验地点
1
主要终点
Improvement in the sign and the symptoms of the

研究概览

简要总结

In the previous research done a significant result has been observed in treating the sign and the symptoms of the otomycosis using different Ayurvedic treatment modalities. Even after the extensive research work has been carried out, Otomycosis is still a challenging disease and remains one of the most established risk factor for the serious complications such as otorrhoea, tympanic perforations and deafness. Hence it is decided to continue the study on otomycosis so as to prove the efficacy of new Ayurvedic intervention and to study it on large population so as to generate more data to evaluate the efficacy of new Ayurveda drug in treating the Otomycosis

研究设计

研究类型
Interventional
分配方式
Coin toss, Lottery, toss of dice, shuffling cards etc
盲法
None

入排标准

年龄范围
16.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • Patient presenting with sign and symptoms of otomycosis.
  • Lakshana of kaphajkarnashoola.
  • Patients willing to give conse.

排除标准

  • Patient having perforated tympanic membrane.
  • Patient of CSOM and ASOM.
  • Patient suffering from systemic diseases like uncontrolled DM, HIV, Hypothyroidism.
  • Immunocompetent and immunocompromised.

结局指标

主要结局

Improvement in the sign and the symptoms of the

时间窗: 40 Days.

kaphajkarnashoola – Otomycosis is expected.

时间窗: 40 Days.

次要结局

未报告次要终点

研究者

发起方
Dr Abhilasha
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr Abhilasha

SKAU, Krukshetra

研究点 (1)

Loading locations...

相似试验